122 related articles for article (PubMed ID: 12568644)
1. Testosterone-buccal--Columbia: COL 1621, Striant, testosterone PHBT, testosterone progressive hydration buccal tablet.
Drugs R D; 2003; 4(1):72-4. PubMed ID: 12568644
[No Abstract] [Full Text] [Related]
2. Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.
Korbonits M; Kipnes M; Grossman AB
Int J Clin Pract; 2004 Nov; 58(11):1073-80. PubMed ID: 15605676
[TBL] [Abstract][Full Text] [Related]
3. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
4. Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.
Harle L; Basaria S; Dobs AS
Expert Opin Pharmacother; 2005 Aug; 6(10):1751-9. PubMed ID: 16086661
[TBL] [Abstract][Full Text] [Related]
5. A long-acting depot formulation of testosterone (Aveed).
Med Lett Drugs Ther; 2014 Mar; 56(1439):26-8. PubMed ID: 24691149
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men.
Ross RJ; Jabbar A; Jones TH; Roberts B; Dunkley K; Hall J; Long A; Levine H; Cullen DR
Eur J Endocrinol; 2004 Jan; 150(1):57-63. PubMed ID: 14713280
[TBL] [Abstract][Full Text] [Related]
7. A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.
Korbonits M; Slawik M; Cullen D; Ross RJ; Stalla G; Schneider H; Reincke M; Bouloux PM; Grossman AB
J Clin Endocrinol Metab; 2004 May; 89(5):2039-43. PubMed ID: 15126518
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
Marbury T; Hamill E; Bachand R; Sebree T; Smith T
Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
[TBL] [Abstract][Full Text] [Related]
9. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.
Wang C; Swerdloff R; Kipnes M; Matsumoto AM; Dobs AS; Cunningham G; Katznelson L; Weber TJ; Friedman TC; Snyder P; Levine HL
J Clin Endocrinol Metab; 2004 Aug; 89(8):3821-9. PubMed ID: 15292312
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic characteristics, efficacy, and safety of buccal testosterone in hypogonadal males: a pilot study.
Dobs AS; Hoover DR; Chen MC; Allen R
J Clin Endocrinol Metab; 1998 Jan; 83(1):33-9. PubMed ID: 9435413
[TBL] [Abstract][Full Text] [Related]
11. [Between physiologic aging and dysfunction. How much testosterone does a man need?].
Volkert R
MMW Fortschr Med; 2005 Mar; 147(11):4-5. PubMed ID: 15803840
[No Abstract] [Full Text] [Related]
12. Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
Pharm Res; 2006 Jun; 23(6):1117-32. PubMed ID: 16755346
[TBL] [Abstract][Full Text] [Related]
13. Testosterone gel for the treatment of male hypogonadism.
de Ronde W
Expert Opin Biol Ther; 2009 Feb; 9(2):249-53. PubMed ID: 19236255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of a new testosterone-in-adhesive matrix patch applied every 2 days to hypogonadal men.
Raynaud JP; Aumonier C; Gualano V; Betea D; Beckers A
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):177-84. PubMed ID: 18325758
[TBL] [Abstract][Full Text] [Related]
15. Testosterone topical solution (Axiron) for hypogonadism.
Med Lett Drugs Ther; 2011 Jul; 53(1368):54-5. PubMed ID: 21738108
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and exogenous testosterone levels after administration of deuterium-labelled testosterone propionate in hypogonadotropic hypogonadism.
Fujioka M; Shinohara Y; Baba S; Irie M; Inoue K
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3100-1. PubMed ID: 2632058
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of testosterone.
Hadgraft J; Lane ME
Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
[TBL] [Abstract][Full Text] [Related]
18. Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs.
Voorspoels J; Remon JP; Eechaute W; De Sy W
Pharm Res; 1996 Aug; 13(8):1228-32. PubMed ID: 8865317
[TBL] [Abstract][Full Text] [Related]
19. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
20. Testosterone treatment of hypogonadal men participating in competitive sports.
Gooren LJ; Behre HM
Andrologia; 2008 Jun; 40(3):195-9. PubMed ID: 18477208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
